市場調查報告書
商品編碼
1410786
胰島素筆市場:市場規模(按細分市場)、份額、監管、報銷、預測(~2033 年)Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
胰島素筆用於注射胰島素以治療糖尿病。它由胰島素筒(一體式或單獨出售)和用於測量劑量的刻度盤組成,並與一次性筆針一起使用來管理劑量。
胰島素筆分為一次性胰島素筆和重複使用型胰島素筆。一次性胰島素筆通常由預先填充的胰島素藥筒組成,一旦小瓶用完,胰島素藥筒就會被丟棄。對於可重複使用的胰島素筆,用完後可以更換筆芯。
本報告深入探討了全球胰島素筆市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。
Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Insulin Pens Devices market for the year 2020 and beyond. Insulin pen is used to inject insulin for the treatment of diabetes. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose.
Insulin pens are classified into disposable and reusable insulin pens. Disposable insulin pens usually consist of pre-filled insulin cartridge which is disposed once the vial is over. In case of reusable insulin pens, the cartridge can be replaced once it is over.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Insulin Pens Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Novo Nordisk AS, Eli Lilly and Co, Sanofi, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable